The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population

• Main Authors: Mesut Öktem (Author), İbrahim Esinler (Author), Derya Eroğlu (Author), Pınar Akkaya (Author), Esra Kuşcu (Author), Hulusi Zeyneloğlu (Author)
• Format: Book
• Published: Medical Network, 2007-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

OBJECTIVE: We aimed to compare the efficacy and tolerability of once-weekly alendronate 70 mg/weekly, risedronate 35 mg/weekly and raloxifene 60 mg/daily in the treatment of postmenopausal osteoporosis. STUDY DESIGN: Retrospective case-control study. 216 aged matched postmenopausal women with osteop...